Research Article

Dextromethorphan Dampens Neonatal Astrocyte Activation and Endoplasmic Reticulum Stress Induced by Prenatal Exposure to Buprenorphine

Figure 1

Prenatal exposure to buprenorphine escalates astrocyte activation in the hippocampus of the neonates concurrent with increased GPR37 immunoreactivity. Prenatal treatments: buprenorphine (Bu), dextromethorphan (Dm), coadministration of buprenorphine with dextromethorphan (Bu+Dm), or vehicle controls (Con). (a) Confocal images (20x objective, left panel) for GPR37 (red) and GFAP (green) immunoreactivity in the hippocampus of neonates, with images at a higher magnification (63x objective) for GPR37 punctate staining (red) in the CA1 (right panel). (b) Western blot analysis of hippocampal GFAP expression levels with quantification. DAPI (blue) staining identifies nuclei. Data are % of control, vs. Con and vs. Con.
(a)
(b)